• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助放疗联合手术切除治疗黏液样脂肪肉瘤的预后因素评估:系统评价

Evaluation of Prognostic Factors in Myxoid Liposarcoma Treated with Combined Neoadjuvant Radiotherapy and Surgical Excision: Systematic Review.

作者信息

Papalia Giuseppe Francesco, De Marco Giulia, Luciano Claudia, Sisca Luisana, Farsetti Pasquale, Vincenzi Bruno, Papalia Rocco

机构信息

Research Unit of Orthopaedic and Trauma Surgery, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, 00128 Rome, Italy.

Oncological Orthopaedics Department, IFO-IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy.

出版信息

Diseases. 2025 Jun 6;13(6):177. doi: 10.3390/diseases13060177.

DOI:10.3390/diseases13060177
PMID:40558588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12192070/
Abstract

PURPOSE

Myxoid liposarcoma (MLPS) is a malignant tumor that occurs predominantly in the deep soft tissues of the extremities. Preoperative radiotherapy (RT) is used to reduce tumor volume to achieve adequate surgical margins. This systematic review aims to evaluate the impact of preoperative RT on surgical margins, local recurrence (LR) rates, metastasis development, and overall survival in patients with MLPS and associated prognostic factors.

METHODS

A systematic literature search was conducted by two reviewers following PRISMA guidelines on PubMed, Scopus, and the Cochrane Library on 30 November 2024. We included prospective and retrospective cohort studies published in English that evaluate surgical margin status, LR and metastasis rates, and survival outcomes in patients undergoing surgical excision of MLPS following neoadjuvant radiotherapy. Two authors extracted tumor characteristics, percentage of round cells (RCs), change in tumor volume post-RT, surgical margins, postoperative complications, LR and metastasis rates, survival rates, and related prognostic factors.

RESULTS

The twelve studies included in this review involved 1483 patients with a mean age of 44.8 years. Tumors were mostly located in the lower limbs, deeply localized, and larger than 5 cm in most cases. The average LR and metastasis rates were 5.2% and 17%, respectively. The mean 5-year and 10-year overall survival rates were 87% and 74%, respectively. Poor prognosis was associated with >5% RC components, tumors larger than 15 cm, deep localization, and inadequate surgical margins.

CONCLUSION

The management of MLPS requires a multidisciplinary approach. Preoperative radiotherapy offers several advantages in reducing tumor volume and facilitating the achievement of adequate surgical margins, finally improving local control and long-term outcomes.

摘要

目的

黏液样脂肪肉瘤(MLPS)是一种主要发生于四肢深部软组织的恶性肿瘤。术前放疗(RT)用于缩小肿瘤体积以获得足够的手术切缘。本系统评价旨在评估术前放疗对MLPS患者手术切缘、局部复发(LR)率、转移发生情况、总生存率及相关预后因素的影响。

方法

两名研究者按照PRISMA指南于2024年11月30日在PubMed、Scopus和Cochrane图书馆进行了系统的文献检索。我们纳入了以英文发表的前瞻性和回顾性队列研究,这些研究评估了新辅助放疗后接受MLPS手术切除患者的手术切缘状态、LR和转移率以及生存结局。两名作者提取了肿瘤特征、圆形细胞(RCs)百分比、放疗后肿瘤体积变化、手术切缘、术后并发症、LR和转移率、生存率及相关预后因素。

结果

本评价纳入的12项研究涉及1483例患者,平均年龄44.8岁。肿瘤大多位于下肢,位置较深,多数情况下直径大于5 cm。平均LR率和转移率分别为5.2%和17%。5年和10年总生存率分别为87%和74%。预后不良与RC成分>5%、肿瘤直径大于15 cm、位置较深及手术切缘不足有关。

结论

MLPS的治疗需要多学科方法。术前放疗在缩小肿瘤体积和促进获得足够手术切缘方面具有诸多优势,最终可改善局部控制和长期预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873f/12192070/fcb4bb93cf78/diseases-13-00177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873f/12192070/fcb4bb93cf78/diseases-13-00177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873f/12192070/fcb4bb93cf78/diseases-13-00177-g001.jpg

相似文献

1
Evaluation of Prognostic Factors in Myxoid Liposarcoma Treated with Combined Neoadjuvant Radiotherapy and Surgical Excision: Systematic Review.新辅助放疗联合手术切除治疗黏液样脂肪肉瘤的预后因素评估:系统评价
Diseases. 2025 Jun 6;13(6):177. doi: 10.3390/diseases13060177.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.早期和极早期肝细胞癌的消融和非手术治疗:系统评价和网络荟萃分析。
Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221.
4
Radiographic and pathologic response of myxoid liposarcoma treated with preoperative radiotherapy.术前放疗治疗黏液样脂肪肉瘤的影像学和病理学反应
Radiol Oncol. 2025 Jun 16;59(2):176-182. doi: 10.2478/raon-2025-0032. eCollection 2025 Jun 1.
5
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
6
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
7
Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.老年新诊断胶质母细胞瘤的治疗:一项网状Meta分析
Cochrane Database Syst Rev. 2020 Mar 23;3(3):CD013261. doi: 10.1002/14651858.CD013261.pub2.
8
Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis.原发性皮肤黑色素瘤的最佳切缘:一项系统评价和荟萃分析。
Can J Surg. 2003 Dec;46(6):419-26.
9
Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.治疗寻常型外阴上皮内瘤变的医学和外科干预措施。
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD011837. doi: 10.1002/14651858.CD011837.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
FUS::DDIT3 Fusion Protein in the Development of Myxoid Liposarcoma and Possible Implications for Therapy.FUS::DDIT3 融合蛋白在黏液样脂肪肉瘤的发生发展中的作用及其对治疗的可能影响。
Biomolecules. 2024 Oct 14;14(10):1297. doi: 10.3390/biom14101297.
2
Diagnosis and Treatment of Myxoid Liposarcoma.黏液样脂肪肉瘤的诊断与治疗。
Curr Treat Options Oncol. 2024 Oct;25(10):1289-1296. doi: 10.1007/s11864-024-01262-9. Epub 2024 Sep 20.
3
Update on Dosing and Fractionation for Neoadjuvant Radiotherapy for Localized Soft Tissue Sarcoma.
局部软组织肉瘤新辅助放疗的剂量和分割更新。
Curr Treat Options Oncol. 2024 Apr;25(4):543-555. doi: 10.1007/s11864-024-01188-2. Epub 2024 Mar 13.
4
Comparison of pre-operative and post-operative radiotherapy in patients with localized myxoid liposarcoma.比较局限性黏液样脂肪肉瘤患者的术前和术后放疗。
Jpn J Clin Oncol. 2023 Dec 7;53(12):1153-1161. doi: 10.1093/jjco/hyad119.
5
Prognostic Factors in Extremity Soft Tissue Sarcomas Treated with Radiotherapy: Systematic Review of the Literature.接受放射治疗的肢体软组织肉瘤的预后因素:文献系统综述
Cancers (Basel). 2023 Sep 9;15(18):4486. doi: 10.3390/cancers15184486.
6
Lack of radiosensitivity predicts poor disease specific survival in myxoid liposarcoma.乏放射敏感性预示黏液样脂肪肉瘤患者疾病特异性生存不良。
J Surg Oncol. 2023 Apr;127(5):848-854. doi: 10.1002/jso.27190. Epub 2022 Dec 27.
7
Evaluation of prognostic factors and oncological outcomes in patients with limb-localized myxoid liposarcoma.评估肢体局限性黏液样脂肪肉瘤患者的预后因素和肿瘤学结果。
Jt Dis Relat Surg. 2022;33(3):616-623. doi: 10.52312/jdrs.2022.799. Epub 2022 Oct 27.
8
Intermuscular extremity myxoid liposarcoma can be managed by marginal resection following neoadjuvant radiotherapy.肌间肢体黏液样脂肪肉瘤可在新辅助放疗后通过边缘切除进行治疗。
Eur J Surg Oncol. 2023 Feb;49(2):362-367. doi: 10.1016/j.ejso.2022.09.008. Epub 2022 Sep 27.
9
Myxomas and myxoid liposarcomas of the extremities: Our preliminary findings in conventional, perfusion, and diffusion magnetic resonance.四肢黏液瘤和黏液样脂肪肉瘤:我们在传统、灌注和扩散磁共振成像方面的初步发现。
Acta Radiol Open. 2022 Oct 7;11(10):20584601221131481. doi: 10.1177/20584601221131481. eCollection 2022 Oct.
10
Radiotherapy, volume reduction, and short-term surgical outcomes in the treatment of large myxoid liposarcomas.放疗、减容与大型黏液样脂肪肉瘤治疗的短期手术结局
Radiat Oncol J. 2022 Sep;40(3):172-179. doi: 10.3857/roj.2022.00094. Epub 2022 Sep 6.